Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of FLUAD versus Vaxigrip in healthy children aged 6 to <36 months
2006-003181-34Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Fluzone Trivalent and influenza vaccine in influenza (3 arms), sponsored by Novartis. Primary endpoints: Post-immunization geometric mean titers and Comparative immunogenicity of two-dose FLUAD versus two-dose Vaxigrip. Started Aug 2006; status: completed.
02
Drugs
Fluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-003181-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003181-34.